Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) EBT: 2018-2024

Historic EBT for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to -$600.8 million.

  • Revolution Medicines' EBT fell 95.28% to -$305.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$961.7 million, marking a year-over-year decrease of 69.70%. This contributed to the annual value of -$600.8 million for FY2024, which is 36.59% down from last year.
  • As of FY2024, Revolution Medicines' EBT stood at -$600.8 million, which was down 36.59% from -$439.9 million recorded in FY2023.
  • Revolution Medicines' EBT's 5-year high stood at -$108.5 million during FY2020, with a 5-year trough of -$600.8 million in FY2024.
  • In the last 3 years, Revolution Medicines' EBT had a median value of -$439.9 million in 2023 and averaged -$430.0 million.
  • Data for Revolution Medicines' EBT shows a maximum YoY tumbled of 108.56% (in 2020) over the last 5 years.
  • Revolution Medicines' EBT (Yearly) stood at -$108.5 million in 2020, then plummeted by 72.39% to -$187.1 million in 2021, then crashed by 33.16% to -$249.1 million in 2022, then tumbled by 76.57% to -$439.9 million in 2023, then slumped by 36.59% to -$600.8 million in 2024.